Seija Grénman

Turku University Hospital — Finland

Medicine · Health Sciences

42h-index7.0kcitations229works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(78), Cervical Cancer and HPV Research(55), Endometrial and Cervical Cancer Treatments(33), Endometriosis Research and Treatment(25), Uterine Myomas and Treatments(22)

Publications229 total

Helicobacter pylori multiplex serology and its dynamics within families during a 3-year prospective follow-up
International Journal of Infectious Diseases·2025Open Access
Gestational diabetes and pregnancy outcome in Kurdish, Somali and general population in Finland
European Journal of Public Health·2024Open Access
Serum Immunoglobulin G Antibodies to Human Papillomavirus Type 6 L1, E2, E4, E6, and E7 Proteins Among Children Prospectively Followed up for 3 Years
The Journal of Infectious Diseases·2024· 2 citedOpen Access
Impact of Different Cofactors on Naturally Acquired Human Papillomavirus Antibody Levels Among Unvaccinated Pregnant Women
Viral Immunology·2024· 1 citedOpen Access
Effect of a Second Pregnancy on the HPV Serology in Mothers Followed Up in the Finnish Family HPV Study
Viruses·2023Open Access
IgG Seroreactivites to Viral Capsid Protein VP1 of JC and BK Polyomaviruses in Children at Early Ages with Special Reference to Parental Cofactors
Children·2023· 1 citedOpen Access
Human Papillomavirus Concordance Between Parents and Their Newborn Offspring: Results From the Finnish Family Human Papillomavirus Study
The Journal of Infectious Diseases·2023· 4 citedOpen Access
HLA-G Alleles Impact the Perinatal Father–Child HPV Transmission
Current Issues in Molecular Biology·2023Open Access
Human polyomavirus BKPyV and JCPyV serostatus has no impact on women´s human papillomavirus infection outcome
Frontiers in Cellular and Infection Microbiology·2023· 1 citedOpen Access
Supplementary material from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Data from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Supplementary material from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Supplementary Table from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Supplementary Table from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Data from Mathematical Modeling Predicts Response to Chemotherapy and Drug Combinations in Ovarian Cancer
2023Open Access
Data from Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum–Taxane Chemotherapy
2023Open Access
Supplementary Figures 1 - 9, Tables 1 - 6 from Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum–Taxane Chemotherapy
2023Open Access
Data from Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum–Taxane Chemotherapy
2023Open Access
Supplementary Figures 1 - 9, Tables 1 - 6 from Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum–Taxane Chemotherapy
2023Open Access
Seroprevalence of polyomaviruses BK and JC in Finnish women and their spouses followed-up for three years
Scientific Reports·2023· 23 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Stina Syrjänen(13), Karí Syrjänen(10), Johanna Hynninen(10), Olli Carpén(10), Ritva Hurskainen(9), Annika Auranen(9), Jorma Paavonen(8), Juha Teperi(5), Aarre Kivelä(5), Erkki Kujansuu(5), ­Eero Pukkala(5), Jaana Rautava(5), Anna‐Mari Aalto(4), Merja Yliskoski(4), Marjut Rintala(4), Kaisa Huhtinen(4), Sampsa Hautaniemi(4), Sinikka Oksa(4), Jukka Kemppainen(4), Tuulia Vallius(4)